Valuation Sprint Bioscience AB

Stocks

Market Closed - Nasdaq Stockholm 19:00:00 15/09/2026 +03			5-day change	1st Jan Change
2.780 ^SEK	+1.46%		-12.85%	+89.12%

08-26	Sprint Bioscience AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-23	Sprint Bioscience AB and Eli Lilly and Company Enter Agreement to Accelerate Drug Development	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027
Market Cap ¹	191.1	22.03	121.1	110.5	155.1	289.1	-
Change	-	-88.47%	449.78%	-8.82%	40.43%	86.39%	-
Enterprise Value (EV)	120.4	-7.459	71.2	85.4	155.1	289.1	289.1
Change	-	-106.19%	1,054.57%	19.94%	81.63%	86.39%	0%
P/E	-5.64x	-	-	-	-	-	-
PBR	-	-	-	-	-	-	-
PEG	-	-	-	-	-	-	-
Capitalization / Revenue	5.44x	265x	2.4x	1.68x	0.93x	3.33x	2.99x
EV / Revenue	0x	-0x	0x	0x	0x	3.33x	2.99x
EV / EBITDA	-0x	0x	-0x	-0x	0x	10.8x	7.51x
EV / EBIT	-0x	0x	-0x	-0x	0x	11.2x	7.71x
EV / FCF	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-
EPS ²	-0.85	-	-	-	-	-	-
Distribution rate	-	-	-	-	-	-	-
Net sales ¹	35.11	0.083	50.48	65.64	167.2	86.8	96.8
EBITDA ¹	-25.04	-60.12	-0.398	-18.71	98.36	26.8	38.5
EBIT ¹	-25.63	-60.74	-0.845	-19.67	97.29	25.7	37.5
Net income	-25.08	-	-	-	-	-	-
Net Debt	-70.64	-29.49	-49.93	-25.06	-	-	-
Reference price ²	4.795	0.553	1.735	1.582	1.470	2.740	2.740
Nbr of stocks (in thousands)	39,844	39,844	69,820	69,820	105,516	105,516	-
Announcement Date	2/16/22 A	2/15/23 A	2/14/24 A	2/12/25 A	2/11/26 A	-	-

¹SEK in Million²SEK

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SPRINT BIOSCIENCE AB	-	-	-	-	29.6M
WUXI APPTEC CO., LTD.	20.63x	7.28x	14.62x	1.44%	70.24B
ARGENX SE	32.28x	9.34x	45.05x	0.04%	62.63B
INSMED INCORPORATED	-76.7x	14.8x	-71.37x	-.--%	27.36B
WUXI BIOLOGICS (CAYMAN) INC.	29.77x	6.32x	16.41x	-.--%	25.71B
BIONTECH SE	-15.03x	5.62x	-7.06x	-.--%	24.83B
GENMAB A/S	26.45x	5.03x	16.73x	-.--%	19.52B
PHARMAESSENTIA CORPORATION	44.88x	16.47x	33.42x	0.34%	15.51B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	1267.62x	36.68x	797.93x	-.--%	14.66B
SUMMIT THERAPEUTICS INC.	-15.8x	3569.89x	-18.25x	-.--%	14.69B
Average	146.01x	407.94x	91.94x	0.2%	27.52B
Weighted average by Cap.	77.53x	200.44x	52.40x	0.4%